Concepedia

Author

Lori A. Schretzman

Portland Cement Association

Also Known As

L. A. SCHRETZMAN, Lori A Schretzman, Lori A. Schretzman, Lori Schretzman

6

Publications

338

Citations

5

H-Index

22

Concepts

All Affiliations

Portland Cement Association
LA

About

Lori A. Schretzman is an author at Portland Cement Association specializing in medicine, drug discovery, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

338

2

Natural Sciences

2

2

211

3

Biochemistry

2

2

211

4

Engineering

1

1

47

5

Biomolecular Engineering

1

1

47

Lori A. Schretzman

×

5

Publications

338

Citations

5

H-Index

YearCitations

Potent in vitro and in vivo inhibitors of platelet aggregation based upon the Arg-Gly-Asp-Phe sequence of fibrinogen. A proposal on the nature of the binding interaction between the Arg-guanidine of RGDX mimetics and the platelet GP IIb-IIIa receptor

Jeffery A. Zablocki, Masateru Miyano, Robert B. Garland,

Journal of Medicinal Chemistry

1993

107

Potent in Vitro and in Vivo Inhibitors of Platelet Aggregation Based Upon the Arg-Gly-Asp Sequence of Fibrinogen. (Aminobenzamidino)succinyl (ABAS) Series of Orally Active Fibrinogen Receptor Antagonists

Jeffery A. Zablocki, Joseph G. Rico, Robert B. Garland,

Journal of Medicinal Chemistry

1995

104

Inhibition of human cytomegalovirus protease by benzoxazinones and evidence of antiviral activity in cell culture

Norman Abood, Lori A. Schretzman, Daniel L. Flynn,

Bioorganic & Medicinal Chemistry Letters

1997

48

Convergent, parallel synthesis of a series of β-substituted 1,2,4-oxadiazole butanoic acids as potent and selective αvβ3 receptor antagonists

Mark L. Boys, Lori A. Schretzman, Nizal S. Chandrakumar,

Bioorganic & Medicinal Chemistry Letters

2005

47

A novel series of orally active antiplatelet agents

Jeffery A. Zablocki, Foe S. Tjoeng, Philippe R. Bovy,

Bioorganic & Medicinal Chemistry

1995

32

Page 1